16 June 2014 12:33

This morning you woke up feeling a little unwell. You have no appetite, your head is aching, your throat is sore and you think you might be slightly feverish. You don’t know it yet, but Ebola virus has started to attack your immune system, wiping out the T-lymphocyte cells that are crucial to its proper function. 

These are the same cells that the AIDS virus (HIV-1) attacks, but Ebola virus kills them far more aggressively. Exactly when and where you caught Ebola virus is unclear, it can take anything between 2 and 21 days from initial infection to the first symptoms. What is more certain is that you are now infectious yourself. Your family, friends and anyone in close contact with you are all in mortal danger.

The next week or so will determine if you are one of the lucky minority who survive. In the 24 Ebola virus outbreaks prior to the present one, a cumulative total of 1590 people, two-thirds of all cases, have died. The current outbreak, which began in the village of Meliandou in eastern Guinea in early December 2013 (see Baizé et al 2014 below), and which has now spread across Guinea and into the neighbouring countries of Sierra Leone and Liberia, has killed 251 people as of 5th June, nearly half of the identified cases (updating my previously reported figures – see Gatherer 2014 below). The west African Ebola epidemic is now the largest outbreak seen so far since Ebola virus was discovered in 1976. The World Health Organization issued its first communiqué on the situation on 23rd March, and since then has been producing regular reports.

Over the next few days your condition deteriorates. Your body aches all over, you have chronic abdominal pain, the fever intensifies and you start to vomit and develop diarrhoea. After anything between a couple of days and a week of misery, you will have reached the crisis point – now the symptoms will either gradually recede or you will progress to the horrors of “cytokine storm”, a convulsion of your ravaged immune system that will plunge you into the terminal phase of Ebola virus disease known as haemorrhagic fever. Cytokine storm releases a torrent of inflammatory molecules into your circulatory system. Your own immune system, now completely out of control, attacks every organ in your body. Tiny blood vessels burst everywhere and you begin slowly to bleed to death. The whites of your eyes turn red, your vomit and diarrhoea are now charged with blood and large blood blisters develop under your skin. You are now at the peak of infectivity as Ebola virus particles, ready to find their next victim, pour out of your body along with your blood.

Fortunately, however, it seems you have survived. Rehydration therapy kept you strong in the initial phase and pure luck saved you from haemorrhagic fever. Understanding why some Ebola virus patients avoid the terminal phase is an active area of research, and one possible answer is that those whose T-lymphocytes survive the initial attack of the virus possibly retain sufficiently intact immune systems. Even when you are merely in the first phase of feeling vaguely unwell, it may be possible to determine if you will live or die. Of course, the main motivation for Ebola research is a cure rather than such fatalistic diagnosis, and there are many promising drug treatments under development as well as a prototype vaccine. These, however, will need to be tested thoroughly for safety and efficacy before general release. For the time being, the only medical response is palliative care, isolation of cases and monitoring of contacts.

Even though you are feeling much improved, and perhaps even ready to return to work, you will remain infectious for a while. All your bodily fluids will still contain virus. In particular, the virus can be sexually transmitted, especially if you are a man, up to 40 days after recovery. Epidemiological modelling studies have shown that Ebola virus is about as infectious as influenza or very slightly more so – each infected person will probably infect 2 to 4 others. That’s not tremendously infectious compared to some of the super-infectious viruses such as measles or polio, which have corresponding numbers of 5 to 18, but it is nevertheless enough to sustain a pandemic. The question of why we haven’t seen a worldwide pandemic of Ebola in pre-modern times therefore becomes rather perplexing. A briefly popular theory of a few years ago, that the Black Death of the 14th century was caused by Ebola virus, and that the famous mediaeval descriptions of buboes were actually haemorrhagic fever blood blisters, has now been convincingly excluded by DNA analyses that have proved beyond doubt that the Black Death was, after all, bubonic plague as originally thought. Ebola may well be a purely modern disease and, since Ebola virus made its first known appearance in 1976, a whole generation of African medical workers have been drilled to be alert to the symptoms of haemorrhagic fever. Consequently, the World Health Organization and its partners have been able to suffocate outbreaks before they spread more generally. However, the latest outbreak is proving rather more recalcitrant than expected and the story is not yet over.

My own research interest is in the evolution of viruses, and how their history is intertwined with that of their hosts. In the field of Ebola research, we still do not know where the virus goes between the devastating periodic outbreaks. We do know that outbreaks occur in large primates other than humans, such as gorillas, where Ebola virus has increased the extinction pressure on these already beleaguered populations. We also know that it is present in three species of fruit bats, where it seems to have little or no effect, and that is where it may live most of the time. This “bat reservoir” theory is now generally accepted, but only two of the three implicated species are found in Guinea – where bat soup, a local delicacy, has now been banned. The first analysis of the Ebola virus genome sequences from Guinea provided some support for the bat reservoir view (see Baizé et al 2014 below). However, a second paper (see Dudas & Rambaut 2014 below) rapidly appeared disputing this conclusion and suggesting that the evidence leans more towards Ebola virus arriving more recently in Guinea from central Africa, although whether transported by a bat or a human is so far not possible to say.

What do you think? Share your comments with us below.

Dr Derek Gatherer teaches on our Biomedical and Life Sciences programmes.

Footnotes:

  1. Dudas G & Rambaut A. Phylogenetic Analysis of Guinea 2014 EBOV Ebolavirus Outbreak. PLOS Currents Outbreaks. 2014 May 2. Edition 1. 
  2. Gatherer D. The 2014 Ebola virus disease outbreak in west Africa. J Gen Virol. 2014 May 2. [Epub ahead of print]
  3. Baizé S et al. Emergence of Zaire Ebola Virus Disease in Guinea - Preliminary Report. N Engl J Med. 2014 Apr 16. [Epub ahead of print]

Disclaimer

The opinions expressed by our bloggers and those providing comments are personal, and may not necessarily reflect the opinions of Lancaster University. Responsibility for the accuracy of any of the information contained within blog posts belongs to the blogger.